Tissue Perfusion Pressure for Predicting Fluid Responsiveness in Patients With Shock

ConditionShock
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorJingyuan,Xu

About this trial

This prospective observational study aims to evaluate the ability of tissue perfusion pressure (TPP) to predict fluid responsiveness in critically ill patients with shock and tissue hypoperfusion. Eligible patients requiring fluid resuscitation will undergo a standardized fluid challenge test. Hemodynamic parameters, including cardiac output and TPP, will be recorded before and after fluid administration. Fluid responsiveness will be defined according to the change in cardiac output following fluid loading. The study will assess the correlation between changes in TPP and cardiac output and evaluate the diagnostic performance of TPP for predicting fluid responsiveness. The results may support the use of TPP as a practical and physiologically relevant parameter for individualized fluid management in patients with shock.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age ≥18 years

Admitted to the Intensive Care Unit (ICU)

Diagnosed with shock and evidence of tissue hypoperfusion

Judged by the treating physician to require fluid resuscitation

Disqualifiers

Pregnancy

Immediate requirement for extracorporeal life support, including: VV-ECMO, VA-ECMO, Ventricular assist devices

Expected survival less than 72 hours

Absence of invasive arterial pressure monitoring or arterial waveform availability <25%

Trial population

The study population will consist of critically ill adult patients with shock and tissue hypoperfusion admitted to the Intensive Care Unit of Zhongda Hospital, Southeast University. Patients requiring fluid resuscitation and invasive hemodynamic monitoring as part of routine clinical care will be screened for eligibility and consecutively enrolled in this prospective observational study.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • When the attending physician determines that fluid resuscitation is clinically indicated: Patients will remain in the supine position. Crystalloid solution will be administered intravenously via centr

    Behavioral

Treatment groups

34 Participants
are divided into 1 treatment group
Group A: all1 intervention

Trial outcomes

Primary outcomes

1

Δ Cardiac output

Time frame
Periprocedural
2

Δ Tissue perfusion pressure

Time frame
Periprocedural

Secondary outcomes

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Jingyuan,Xu

Lead sponsor

Southeast University, China

Sponsor institution

This trial is not recruiting at the moment. You can still explore other options: